-
1. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses. Gastric Cancer 2023;26(1):95-107
Urabe M, Matsusaka K, Ushiku T, Fukuyo M, Bahityar R, Yamashita H, Seto Y, Fukayama M, Kaneda A.
-
2. Duodenal diversion surgery in management of intractable tracheobroncho-gastric fistula after esophagectomy. Gen Thorac Cardiovasc Surg Case 2023:2(1):58
Urabe M, Yagi K, Yoshimura S, Ri M, Yajima S, Okumura Y, Seto Y.
-
3. Laparoscopic and endoscopic cooperative surgery as palliative treatment for elderly patients with gastric cancer. Nagoya J Med Sci 2023;85(4):807-13
Urabe M, Okumura Y, Okamoto A, Yagi K, Tsuji Y, Yamashita H, Fujishiro M, Seto Y.
-
4. Esophageal cancer surgery in dialyzed patients: a single institution case series. Ann Thorac Cardiovasc Surg 2022;28(5):366-70
Urabe M, Ueno M, Yago A, Shimoyama H, Ohkura Y, Haruta S, Udagawa H.
-
5. Implications of liver-directed therapy for postoperative hepatic metastasis from esophageal cancer. J Chest Surg 2022;55(5):397-404
Urabe M, Yagi K, Shiomi S, Toriumi T, Okumura Y, Seto Y.
-
6. Coexistence of aberrant left hepatic artery and duplicated left gastric artery: a potential surgical pitfall. ANZ J Surg 2022;92(6):1551-2
Urabe M, Haruta S, Ueno M.
-
7. Factors affecting blood loss during thoracoscopic esophagectomy for esophageal carcinoma. J Chest Surg 2021;54(6):466-72
Urabe M, Ohkura Y, Haruta S, Ueno M, Udagawa H.
-
8. Spontaneous mesenteric haematoma: a diagnostic dilemma. ANZ J Surg 2021;91(9):1941-3
Urabe M, Kojima K, Kinowaki K, Haruta S, Ueno M.
-
9. Management and outcomes of resectable gastric conduit cancer: a retrospective comparative study of 51 cases. Langenbecks Arch Surg 2021;406(5):1433-41
Urabe M, Haruta S, Tanaka M, Yago A, Ohkura Y, Tanaka T, Hoteya S, Ueno M, Udagawa H.
-
10. Comparative analysis of the prognostic utility of preoperative nutritional parameters in patients with resectable esophageal carcinoma. Gen Thorac Cardiovasc Surg 2021;69(2):326-35
Urabe M, Ueno M, Ogawa Y, Yago A, Shimoyama H, Honda A, Ohkura Y, Haruta S, Udagawa H.
-
11. Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: experiences related to esophageal cancer surgery. Head Neck 2020;42(10):3098-9
Urabe M, Ueno M, Udagawa H.
-
12. Factors impacting survival outcomes after curative resection for primary duodenal adenocarcinoma. Surg Gastroenterol Oncol 2020;25(3):132-9
Urabe M, Shindoh J, Kobayashi Y, Okubo S, Haruta S, Ueno M, Hashimoto M.
-
13. Percutaneous endoscopic gastrostomy with jejunal extension for a post-esophagectomy gastric conduit. Clin J Gastroenterol 2020;13(4):501-5
Urabe M, Koga S, Ohkura Y, Ueno M, Udagawa H.
-
14. Diaphragmatic herniation following total gastrectomy: review of the long-term experience of a tertiary institution. Langenbecks Arch Surg 2019;404(8):993-8
Urabe M, Haruta S, Ohkura Y, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H.
-
15. Prognostic significance of neutrophil-to-lymphocyte ratio in solid tumors: a note on methodological concerns. Biomark Med 2019;13(17):1429-32
Urabe M, Yamashita H, Seto Y.
-
16. Clinicopathological presentations and surgical outcomes of esophageal melanoma. Asian Cardiovasc Thorac Ann 2019;27(7):548-53
Urabe M, Haruta S, Ohkura Y, Inoshita N, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H.
-
17. Giant Brunner’s gland adenoma of the duodenum manifested by melena. ANZ J Surg 2019;89(9):1166-7
Urabe M, Yamashita H, Nishida M, Seto Y.
-
18. Gastric cancer with solitary liver metastasis accompanied by cyst formation. ANZ J Surg 2019;89(6):784-5
Urabe M, Yamashita H, Akamatsu N, Seto Y.
-
19. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort. Cancer Med 2018;7(10):5145-54
Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.
-
20. Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner. Jpn J Clin Oncol 2018;48(4):343-9
Urabe M, Yamashita H, Uemura Y, Tanabe A, Yagi K, Aikou S, Seto Y.
-
21. Comparison of prognostic abilities among preoperative laboratory data indices in patients with resectable gastric and esophagogastric junction adenocarcinoma. World J Surg 2018;42(1):185-94
Urabe M, Yamashita H, Watanabe T, Seto Y.
-
22. Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in patients with resectable gastroesophageal junction and gastric cancer. Ann Surg 2017;266(6):e76-7
Urabe M, Yamashita H, Seto Y.
-
23. Pathologic response of HER2-positive gastric cancer to trastuzumab-based chemotherapy. Am J Surg Pathol 2016;40(10):1326-33
Urabe M, Ushiku T, Seto Y, Fukayama M.
-
24. Solitary fibrous tumor of the greater omentum, mimicking gastrointestinal stromal tumor of the small intestine: a case report. Int Surg 2015;100(5):836-40
Urabe M, Yamagata Y, Aikou S, Mori K, Yamashita H, Nomura S, Shibahara J, Fukayama M, Seto Y.
-
25. Primary adenocarcinoma in the middle thoracic esophagus, which revealed scirrhous-like growth. Esophagus 2014;12(4):365-9
Urabe M, Mori K, Nishida M, Yagi K, Yamagata Y, Aikou S, Yamashita H, Nomura S, Shinozaki-Ushiku A, Fukayama M, Seto Y.
